Skip to main content

Rigel Pharmaceuticals Inc 10-Q for FY2021 Q1

Rigel Pharmaceuticals Inc (RIGL)

10-Q 2021-05-05 For: 2021-03-31
View Original
Added on April 06, 2026

About this 10-Q

Rigel Pharmaceuticals Inc filed this 10-Q on May 5, 2021, covering the quarter ended March 31, 2021 (FY2021 Q1).

Headline figures

Quarter ended March 31, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$81.02M
up 45.3% from $55.76M a year earlier
Net income
$39.5M
up 85.9% from net income of $21.24M a year earlier
Diluted EPS
$0.22
up 69.2% from $0.13 a year earlier